Evidence map›Paper›PMID 27165635›Full record

ArticleNeurochemical research2016

Repeated LPS Injection Induces Distinct Changes in the Kynurenine Pathway in Mice.

M K Larsson, A Faka, M Bhat, S Imbeault, M Goiny, F Orhan, A Oliveros, S Ståhl, X C Liu, D S Choi and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Neurochemical research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.3field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Effects of Current Psychotropic Drugs on Inflammation and Immune System.Advances in experimental medicine and biology · 2023
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Anti-inflammatory Strategies for Schizophrenia: A Review of Evidence for Therapeutic Applications and Drug Repurposing.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2020
    Article
  17. Changes in brain kynurenine levelsFASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

M K LarssonDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
A FakaDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
M BhatProtein Biomarkers, Personalized Healthcare and Biomarkers Laboratories, Innovative Medicines, AstraZeneca, Gothenburg, Sweden.
S ImbeaultDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
M GoinyDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
F OrhanDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
A OliverosDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, MN, 55905, USA.
S StåhlTranslational Science Centre, Personalized Healthcare and Biomarkers Laboratories, Innovative Medicines, Science for Life Laboratory, AstraZeneca, Stockholm, Sweden.
X C LiuDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
D S ChoiDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, MN, 55905, USA.
K SandbergDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
G EngbergDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
L SchwielerDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
S ErhardtDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden. sophie.erhardt@ki.se.ORCID http://orcid.org/0000-0001-7359-5250
Karolinska Institutet · SEMayo Clinic · USAstraZeneca (Sweden) · SEScience for Life Laboratory · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The immune system has been recognized as a potential contributor to psychiatric disorders. In animals, lipopolysaccharide (LPS) is used to induce inflammation and behaviors analogous to some of the symptoms in these disorders. Recent data indicate that the kynurenine pathway contributes to LPS-induced aberrant behaviors. However, data are inconclusive regarding optimal LPS dose and treatment strategy. Here, we therefore aimed to evaluate the effects of single versus repeated administration of LPS on the kynurenine pathway. Adult C57BL6 mice were given 0.83 mg/kg LPS as a single or a repeated injection (LPS + LPS) and sacrificed after 24, 48, 72, or 120 h. Mice receiving LPS + LPS had significantly elevated brain kynurenine levels at 24 and 48 h, and elevated serum kynurenine at 24, 48 and 72 h. Brain kynurenic acid and quinolinic acid were significantly increased at 24 and 48 h in mice receiving LPS + LPS, whereas serum kynurenic acid levels were significantly decreased at 24 h. The increase of brain kynurenic acid by LPS + LPS was likely unrelated to the higher total dose as a separate group of mice receiving 1.66 mg/kg LPS as single injection 24 h prior to sacrifice did not show increased brain kynurenic acid. Serum quinolinic acid levels were not affected by LPS + LPS compared to vehicle. Animals given repeated injections of LPS showed a more robust induction of the kynurenine pathway in contrast to animals receiving a single injection. These results may be valuable in light of data showing the importance of the kynurenine pathway in psychiatric disorders.

Indexed as

AnimalsBrainImmune SystemInflammationKynurenic AcidKynurenineLipopolysaccharidesMaleMice, Inbred C57BLQuinolinic AcidKynurenic AcidKynurenineLipopolysaccharidesQuinolinic AcidKynurenic acidKynurenine pathwayLipopolysaccharideNeuroinflammationPsychiatric disordersQuinolinic acid

Identifiers

PMID27165635
OpenAlexW2372817497

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.